A share price of Staar Surgical Co. [STAA] is currently trading at $48.68, up 6.97%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The STAA shares have gain 27.17% over the last week, with a monthly amount glided 37.13%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 4, April 2024, STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024. In a post published today on Yahoo Finance, Total Net Sales in Excess of $77 Million.
From an analyst’s perspective:
Staar Surgical Co. [NASDAQ: STAA] stock has seen the most recent analyst activity on March 11, 2024, when Stifel upgraded its rating to a Buy and also boosted its price target to $50 from $30. Previously, Needham downgraded its rating to Hold on December 05, 2023. On December 04, 2023, Morgan Stanley initiated with a Equal-Weight rating and assigned a price target of $35 on the stock. The Benchmark Company downgraded its rating to a Hold. Canaccord Genuity downgraded its rating to a Hold and reduced its price target to $48 on August 03, 2023. William Blair downgraded its rating to Mkt Perform for this stock on June 07, 2023. In a note dated April 17, 2023, Piper Sandler initiated an Neutral rating and provided a target price of $65 on this stock.
Staar Surgical Co. experienced fluctuations in its stock price throughout the past year between $26.66 and $73.13. Currently, Wall Street analysts expect the stock to reach $63.81 within the next 12 months. Staar Surgical Co. [NASDAQ: STAA] shares were valued at $48.68 at the most recent close of the market. An investor can expect a potential return of 31.08% based on the average STAA price forecast.
Analyzing the STAA fundamentals
Trailing Twelve Months sales for Staar Surgical Co. [NASDAQ:STAA] were 322.42M which represents 19.09% growth. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.1%, and Net Profit Margin reading is 0.07%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.06 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 46.04 points at the first support level, and at 43.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.08, and for the 2nd resistance point, it is at 51.47.
Staar Surgical Co. [STAA] reported earnings per share of $0.13 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.17/share, meaning a difference of -$0.04 and a surprise factor of -23.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.3 per share as compared to estimates of $0.18 per share, a difference of $0.12 representing a surprise of 66.70%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Staar Surgical Co. [NASDAQ:STAA] is 5.62. As well, the Quick Ratio is 5.08, while the Cash Ratio is 2.81. Considering the valuation of this stock, the price to sales ratio is 7.38, the price to book ratio is 6.16 and price to earnings (TTM) ratio is 112.61.
Transactions by insiders
Recent insider trading involved WEISNER AIMEE S, Director, that happened on Mar 14 ’24 when 1750.0 shares were purchased. 10% Owner, BROADWOOD PARTNERS, L.P. completed a deal on Jan 08 ’24 to buy 4042.0 shares. Meanwhile, 10% Owner BROADWOOD PARTNERS, L.P. bought 0.16 million shares on Jan 05 ’24.
